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Edited by Richard MaraisAbstract The norepinephrine-driven increase in mitogen-acti-
vated protein kinase (MAPK) activity is part of the mechanism
that regulates arylalkylamine N-acetyltransferase (AA-NAT)
activity in the rat pineal gland. We now report a marked
nocturnal increase in the expression of a MAPK phosphatase,
MAP kinase phosphatase-1 (MKP-1), that was blocked by
maintaining animals in constant light or treatment with pro-
pranolol. MKP-1 expression was regulated by norepinephrine
acting through both a- and b-adrenergic receptors. These results
establish a nocturnal increase in pineal MKP-1 expression that is
under the control of a photoneural system. Because substrates of
MKP-1 can inﬂuence AA-NAT activity, our ﬁndings suggest the
involvement of MKP-1 in the regulation of the nocturnal AA-
NAT signal.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Circadian; Adrenergic; Photoneuroendocrinology1. Introduction
The rat pineal gland is stimulated by the nightly release of
norepinephrine (NE) from the sympathetic nerve terminals,
resulting in the activation of both a- and b-adrenergic recep-
tors [1]. Stimulation of b-adrenergic receptors produces a 4- to
10-fold increase in cAMP and cGMP accumulation [1]. Stim-
ulation of a-adrenergic receptors, which has no apparent in-
dependent eﬀect on cAMP or cGMP accumulation,
potentiates the b-adrenergic response resulting in a 50- to 100-
fold increase in cAMP and cGMP accumulation [1–5]. cAMP
acts through multiple mechanisms to increase arylalkylamine-* Corresponding author. Fax: +1-780-492-8915.
E-mail address: cchik@ualberta.ca (C.L. Chik).
Abbreviations: MKP-1, MAP kinase phosphatase-1; NE, norepineph-
rine; AA-NAT, arylalkylamine-N-acetyltransferase; MAPK, mitogen-
activated protein kinase; ZT, zeitgeber time; GAPDH, glyceraldehyde-
3-phosphate-dehydrogenase; SCN, suprachiasmatic nucleus
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doi:10.1016/j.febslet.2004.09.083N-acetyltransferase (AA-NAT) activity, the rate-controlling
enzyme in melatonin biosynthesis [6–9].
In contrast to the established role of cAMP in pineal
physiology, the importance of NE-stimulated cGMP accu-
mulation in this tissue is only now beginning to become
clear. The nocturnal activation of p42/44 mitogen-activated
protein kinase (p42/44MAPK) and its downstream kinase, the
90 kDa ribosomal S6 kinase, is primarily regulated by the
NE! cGMP pathway [10–13]. Moreover, the NE activation
of p42/44MAPK is modulated by the state of p38MAPK acti-
vation [14] and activation of AA-NAT activity by NE is
modulated by MAPKs, speciﬁcally p42/44MAPK and
p38MAPK [13,15]. Likewise, MAPK phosphatases are likely
to play an important role in the regulation of pineal func-
tion, because the magnitude and duration of signaling
through MAPKs reﬂects a balance between the upstream
activators and a complex regulatory network of protein
phosphatases [16–19].
One of these phosphatases, a dual speciﬁcity phosphatase,
MAPK phosphatase-1 (MKP-1), is of special interest; MKP-1
is an important regulator of MAPK activity in a wide array of
physiological processes [16–20]. Results from microarray
analysis of pineal glands suggest thatMKP-1 mRNA increases
when AA-NAT activity increases [21,22]; this is of interest
because it points to the possibility that MKP-1 may play a role
in controlling melatonin production through control of
MAPKs. Accordingly, in the studies presented here, the
physiological and neural regulation of MKP-1 mRNA and
protein were investigated.2. Materials and methods
2.1. Materials
NE, isoproterenol, phenylephrine, prazosin and propranolol were
obtained from Sigma Aldrich Co. (St. Louis, MO). Polyclonal anti-
MKP-1 serum was obtained from Santa Cruz Biotechnology (Santa
Cruz, CA). Monoclonal anti-glyceraldehyde-3-phosphate-dehydroge-
nase (GAPDH) serum was obtained from Ambion Inc. (Austin, TX).
Polyclonal anti-AA-NAT25–200 (AB3314) was raised in rabbit against a
rat peptide rAA-NAT25–200 [15]. All other chemicals were of the purest
grades available commercially.blished by Elsevier B.V. All rights reserved.
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All procedures were reviewed and approved by the Health Sciences
Animal Policy and Welfare Committee of the University of Alberta.
Sprague Dawley rats (male; weighing 150 g) were obtained from the
University of Alberta animal unit. Animals were housed under a
lighting regimen providing 12 h of light every 24 h with lights on at
06:00 h [zeitgeber time zero (ZT0)]. For pinealocyte cell culture, ani-
mals were killed 3 h after the onset of light by decapitation, and pineal
glands were removed and stored in ice-cold PBS until trypsinization.
For analysis of the pineal glands, groups of animals (n ¼ 3–6 per
groups) were killed at various time points as indicated, with one group
kept in a lighted environment for an additional 3 h after the onset of
darkness, one group kept in constant darkness for 48 h, one group
exposed to light at ZT16, and another group injected intraperitoneally
with aqueous propranolol solution (1 mg/kg body weight) 1 h prior to
the onset of darkness. Pineal glands were cleansed in ice cold PBS,
frozen on dry ice and stored at )75 C until preparation for Western
blot analysis or RNA extraction. When animals were killed during the
dark period, illumination was provided by a dim red light (Bright Lab
Jr Safelight, CPM Inc, Dallas, TX).
2.3. Preparation of cultured pinealocytes and drug treatment
Pinealocytes were prepared by trypsinization of freshly dissected rat
pineal glands as described previously [23]. Cells were suspended in
DMEM containing 10% fetal calf serum and maintained before the
experiments at 37 C for 24 h in a mixture of 95% air and 5% CO2.
Cells (0.8 105 cells/0.3 ml DMEM) were treated with diﬀerent drugs
for the time periods indicated. Treated cells were collected by centri-
fugation (2 min, 12 000 g). Samples for Western blot analysis were
boiled for 5 min in 1x sample buﬀer and stored at )20 C until analysis.
2.4. Preparation of pineal glands for western blot analysis
Frozen pineal glands were homogenized in buﬀer (20 mM Tris–HCl;
2 mM EDTA; 0.5 mM EGTA; 2 mM phenylmethylsulfonylﬂuoride; 1
lg/ml each of aprotinin, leupeptin, and pepstatin (Sigma Aldrich Co.);
1 mM sodium vanadate; and 1 mM sodium ﬂuoride, pH 7.5) by son-
ication. An aliquot of the homogenate was used for protein determi-
nation [24]. After adjusting for protein content, samples were mixed
with 2 sample buﬀer, boiled for 5 min, and stored at )20 C until
electrophoresis. SDS–PAGE was performed according to the proce-
dure of Laemmli [25] and described in our previous studies [10–15]
using 10% acrylamide and 1 mg/ml sodium dodecyl sulfate (Mini-
Protein II gel system, Bio-Rad Laboratories, Inc., Hercules, CA).
2.5. RT-PCR
Total RNA was isolated from both cultured pineal cells and intact
frozen glands using RNeasy RNA extraction kits (Qiagen Inc., Va-
lencia, CA). Frozen pineal glands were thawed in the supplied lysis
buﬀer and homogenized with a plastic homogenizer before proceeding
with RNA extraction. First strand cDNA was synthesized from the
isolated RNA using an Omniscript reverse-transcriptase kit (Qiagen
Inc., Valencia, CA) with an oligo-dT primer. For gland extracts, 1 ll of
a 1:10 dilution of cDNA in PCR-grade water was used as template for
PCRs. For cell extracts, 3 ll of a 1:10 dilution of cDNA was used.
PCR was performed in a 29.3 ll reaction mixture containing 10 mM
Tris, pH 8.3, 50 mMKCl, 1.5 mMMgCl2, 100 lM of each dNTP, 0.75
U Taq polymerase (Perkin–Elmer Cetus, Emeryville, CA) and 1 lM
each of the two primers. PCRs were as follows: denaturing for 1 min at
94 C, annealing for 1 min at 63 C, and extension for 1 min at 72 C.
Initial denaturing and ﬁnal extension were both 5 min in duration.
Cycle numbers varied slightly between cell preparations, but in general,
22 cycles were used to amplify GAPDH, and 25 cycles to amplify both
MKP-1 and AA-NAT mRNAs. All reaction sets included water blanks
as negative controls. Ampliﬁed products were separated on ethidium
bromide-stained 1.5% agarose gels. PCR products were conﬁrmed by
sequencing. All primer sequences were designed using rat gene cDNA
sequences obtained from BLAST [26] and primers were selected from
30 regions as outlined in [27]. Primers used are as follows: MKP-1: left
primer: 50-CTG CTT TGA TCA ACG TCT CG-30; right primer: 50-
AAG CTG AAG TTG GGG GAG AT-30; AA-NAT: left primer: 50-
GGT TCA CTT TGG GAC AAG GA-30; right primer: 50-GTG GCA
CCG TAA GGA ACA TT-30. Sequences of the GAPDH primers used
were previously described [28].
Real time RT-PCR based on SYBR green ﬂuorescence (Molecular
Probes, Inc., Eugene, OR) was used to provide a relative quantiﬁcationofMKP-1 and AA-NAT [29]. This was performed with an ABI PRISM
7900HT Sequence Detection System (Applied Biosystems, Foster City,
CA). Template cDNA samples were diluted 10-fold and serial 4-fold
dilutions (from 1:4 to 1:65 536) were analyzed on a 384 well plate.
cDNA template samples were standardized by their OD260 readings
and incorporation curves forMKP-1 and AA-NAT were normalized to
a standard curve constructed for ampliﬁcation of GAPDH for each
sample.
2.6. Results and statistical analysis
For quantitation of RT-PCR analyses, gel images were acquired
with Kodak 1-D software on a Kodak 2000R imaging station (East-
man Kodak Co., Rochester, NY). For analyses of Western blots, ex-
posed ﬁlms were scanned and band densitometry of acquired images
was performed with Kodak 1-D software. For comparison, densito-
metric and real time RT-PCR values were normalized so that peak
values equal 100%. Data are presented as meansS.E.M. from at least
three independent experiments. Statistical analysis involved either a
paired t test or ANOVA with the Newman–Keuls test. Statistical
signiﬁcance was set at P < 0:05.3. Results
3.1. MKP-1 expression is induced at night in the rat pineal
gland (Fig. 1)
A rapid nocturnal increase in pineal MKP-1 mRNA levels
occurred with peak values observed at ZT15. The increase in
MKP-1 mRNA occurred more rapidly than that of AA-NAT
mRNA. Between ZT15 and ZT19, MKP-1 mRNA abundance
rapidly declined; this diﬀers from the nocturnal increase in AA-
NAT mRNA, which exhibited a sustained elevation between
ZT17 and ZT22. Real time RT-PCR analysis showed an 100-
fold increase inMKP-1mRNA level at ZT15. At ZT18,MKP-1
mRNA level was only 35% of the level at ZT15 (P < 0:05),
while AA-NAT mRNA level was 3-fold higher (P < 0:05)
(Fig. 1C). In the same experiment, MKP-1 protein increased
with a peak at ZT15 followed by a rapid decline and the peak
AA-NAT protein level occurred between ZT19 and ZT22
(Fig. 1B) as in previous studies [7,9].3.2. MKP-1 expression is reduced by injection of a b-blocker, is
blocked by constant light and persists in constant darkness
The role of adrenergic stimulation in the nocturnal induction
of MKP-1 expression was investigated using treatments that
reduce or block adrenergic stimulation of AA-NAT mRNA in
the pineal gland [7], i.e., b-adrenergic blockade and constant
light at night. Treatment with propranolol (1 mg/kg intraper-
itoneally) 1 h before onset of darkness reduced the nocturnal
induction of MKP-1 mRNA by 60% at ZT15; in the same
experiment, this treatment reduced AA-NAT mRNA by 85%
(Fig. 2A). Analysis of protein levels indicated that propranolol
treatment had a small eﬀect on pineal MKP-1 protein, but
reduced AA-NAT protein by 75% (Fig. 2B). Whereas pro-
pranolol treatment produced partial inhibition of the increases
in mRNA and protein, constant light treatment completely
abolished the nocturnal induction of MKP-1 and AA-NAT
mRNA and protein. The nocturnal induction of MKP-1 ex-
pression in subjective night (ZT15) persisted in animals ex-
posed to constant darkness for 48 h (Fig. 3).
3.3. Neural stimulation of the pineal gland at night is blocked by
exposure to light (Fig. 4)
To investigate whether exposure to light in the middle of
the night could alter MKP-1 mRNA and protein expression,
Fig. 1. MKP-1 is nocturnally expressed in the rat pineal. Pineal glands were collected from rats at the time points indicated. (A) Upper panel:
representative ethidium bromide-stained agarose gels showing RT-PCR-ampliﬁed fragments of theMKP-1 and AA-NAT mRNAs, GAPDH mRNA
included to demonstrate loading consistency. Lower panel: densitometric measurements of MKP-1 and AA-NAT mRNAs presented as % of peak
value (n ¼ 3–5 per group). (B) Upper panel: representative immunoblots of MKP-1 (40 kDa) and AA-NAT (23kDa) proteins, GAPDH (37 kDa)
included to validate loading. Lower panel: densitometric measurements of MKP-1 and AA-NAT proteins presented as % of peak value (n ¼ 3–5 per
group). (C) Real time RT-PCR analysis of MKP-1 and AA-NAT mRNAs. Histograms of real time RT-PCR MKP-1 and AA-NAT mRNAs,
normalized to GAPDH mRNA, expressed as % of the maximal increase (n ¼ 3).
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exposed to light at ZT16; pineal glands were obtained at 30 min
intervals for the next 90 min. This treatment caused MKP-1
mRNA to decrease to day levels within 30min and had a similar
rapid impact on AA-NAT mRNA. In addition, this treatment
caused MKP-1 and AA-NAT protein levels to return to day
levelswithin 1 h. In contrast, in control animals in the dark, there
was only a small decline in pineal MKP-1 mRNA and protein
levels between ZT16 and ZT17.5, while AA-NAT mRNA and
protein levels were higher at ZT17.5 (see Figs. 4–6).
3.4. MKP-1 expression is induced following NE stimulation of
cultured pinealocytes (Fig. 5)
To conﬁrm that MKP-1 expression is under adrenergic
control, isolated pinealocytes were treated with NE (3 lM) for
4 h; this caused a rapid increase in MKP-1 mRNA levels that
peaked at 1 h and declined gradually over the next 4 h. In the
same experiment, this treatment caused a gradual increase in
AA-NATmRNA levels that peaked between 3 and 4 h. MKP-1
and AA-NAT proteins changed in parallel with mRNA levels
following NE treatment.3.5. Dual a- and b-adrenergic control of MKP-1 expression in
rat pinealocytes (Fig. 6)
The subtype of adrenergic receptors involved in pineal
MKP-1 expression was investigated in culture using selective
adrenergic antagonists at doses which produced a- and b-ad-
renergic selective eﬀects in this system [3–5]. NE-induced
MKP-1 mRNA expression was reduced by treatment with
prazosin (3 lM) or propranolol (3 lM) and blocked by the
combined treatment with prazosin and propranolol. In con-
trast, propranolol alone was eﬀective in inhibiting the NE-
induced AA-NAT mRNA expression. The decreases in
NE-stimulated MKP-1 and AA-NAT protein levels paralleled
the corresponding reduction in mRNA levels.4. Discussion
In many physiological processes mediated by growth factors
or stress stimuli, MKP-1 is an immediate early gene that is
induced to target inactivation of MAPKs [18,19]. In rat pi-
nealocytes, the activation states of p42/44MAPK and p38MAPK
Fig. 2. MKP-1 induction is blocked by constant light and reduced by injection of a b-blocker. Pineal glands were collected from rats at ZT12, ZT15,
ZT15 with propranolol treatment (1 mg/kg IP at ZT11) (+prop), and ZT15 with light remaining on from ZT12 (+light). (A) Upper panel: repre-
sentative ethidium bromide-stained agarose gels showing MKP-1, AA-NAT and GAPDH mRNAs. Lower panel: densitometric measurements of
MKP-1 and AA-NAT mRNAs presented as % of peak value. (B) Upper panel: immunoblots of MKP-1, AA-NAT and GAPDH proteins. Lower
panel: densitometric measurements of MKP-1 and AA-NAT proteins presented as % of peak value (n ¼ 3 for ZT12 and ZT15+light, n ¼ 6 for ZT15
and ZT15+prop). P < 0:05, compared with ZT15.
Fig. 3. MKP-1 induction persists in constant darkness. Pineal glands were collected at ZT11 and ZT15 from rats subjected to either 12 h of light every
24 h with lights on at 06:00 h (LD) or 48 h of constant darkness (DD). (A) Upper panel: representative ethidium bromide-stained agarose gels
showing MKP-1, AA-NAT and GAPDH mRNAs. Lower panel: densitometric measurements of MKP-1 and AA-NAT mRNAs presented as % of
peak value (n ¼ 4). (B) Upper panel: immunoblots of MKP-1, AA-NAT and GAPDH proteins. Lower panel: densitometric measurements of MKP-1
and AA-NAT proteins presented as % of peak value (n ¼ 4).
D.M. Price et al. / FEBS Letters 577 (2004) 220–226 223can be increased by NE stimulation [11,15]; similarly, there is a
nocturnal increase in p42/44MAPK and p38MAPK activity in the
pineal glands [12,30]. In view of the evidence that NE control
of AA-NAT activity is modulated by p42/44MAPK and
p38MAPK [15,17], it appears that MKP-1 may shape the noc-
turnal MT signal in rats by regulating the activities of MAPKs.Results from the present studies demonstrate that the
marked nocturnal induction of MKP-1 expression is tightly
regulated by environmental lighting and under adrenergic
control. This is based on observations that pineal MKP-1
mRNA and protein levels increase at night and that subjecting
the animals to constant light from the onset of darkness is
Fig. 4. Neural stimulation of the pineal gland at night is blocked by exposure to light. Pineal glands were collected at the time points indicated in the
absence or presence of acute light exposure at ZT16. (A) Upper panel: representative ethidium bromide-stained agarose gels showing MKP-1, AA-
NAT and GAPDH mRNAs. Lower panel: densitometric measurements of MKP-1 and AA-NAT mRNAs presented as % of peak value (n ¼ 3).
(B) Upper panel: representative immunoblots of MKP-1, AA-NAT and GAPDH proteins. Lower panel: densitometric measurements of MKP-1 and
AA-NAT proteins presented as % of peak value (n ¼ 3).
Fig. 5. MKP-1 is induced by NE treatment of rat pinealocytes. Pinealocytes (0.8 105 cells/0.3 ml) were cultured for 24 h and treated with NE (3 lM)
for diﬀerent time periods. (A) Upper panel: representative ethidium bromide-stained agarose gels showingMKP-1, AA-NAT and GAPDH mRNAs.
Lower panel: densitometric measurements of MKP-1 and AA-NAT mRNAs presented as % of peak value (n ¼ 4). (B) Upper panel: representative
immunoblots of MKP-1, AA-NAT and GAPDH proteins. Lower panel: densitometric measurements of MKP-1 and AA-NAT proteins presented as
% of peak value (n ¼ 4). Con ¼ control, P < 0:05, compared with time 0.
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and protein levels. The nocturnal induction of pineal MKP-1
expression is also reduced by injection of the b-blocker pro-
pranolol. It is known that NE release at night in the pineal
gland is driven by the endogenous circadian clock in the sup-
rachiasmatic nucleus (SCN) [31,32]; accordingly, it would ap-
pear that the daily rhythm in MKP-1 expression in the ratpineal gland is driven by the SCN. This is supported by our
ﬁnding that the nocturnal induction of MKP-1 expression
persists in constant darkness.
The observation that the nocturnal induction of pinealMKP-
1 expression is completely blocked by exposing animals to
constant light, but reduced by injection of the b-blocker pro-
pranolol suggests the involvement of mechanisms not regulated
Fig. 6. NE-stimulated MKP-1 expression in rat pinealocytes is reduced by pre-treatment with both a- and b-blockers. Pinealocytes (0.8 105 cells/0.3
ml) were cultured for 24 h and treated with NE (3 lM) in the absence or presence of prazosin (Praz, 3 lM), propranolol (Prop, 3 lM), or Praz (3
lM)+Prop (3 lM) for 3 h. (A) Upper panel: representative ethidium bromide-stained agarose gels showingMKP-1, AA-NAT and GAPDHmRNAs.
Lower panel: densitometric measurements of MKP-1 and AA-NAT mRNAs presented as % of peak value (n ¼ 4). (B) Upper panel: representative
immunoblots of MKP-1, AA-NAT and GADPH proteins. Lower panel: densitometric measurements of MKP-1 and AA-NAT proteins presented as
% of peak value (n ¼ 4). Con ¼ control, P < 0:05, compared with NE.
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cell culture studies that showed involvement of both a- and b-
adrenergic receptor mechanisms in the NE-induced MKP-1
expression. Blockade of either a- or b-adrenergic receptors is
eﬀective in reducing NE-stimulated MKP-1 expression but
blockade of both receptors are required to abolish the NE-
stimulated response. Whereas our results support that MKP-1
is regulated by an adrenergic system, additional studies are re-
quired to fully describe the contributions of a- and b-adrenergic
receptors to the in vivo regulation of this gene.
Comparisons of the temporal proﬁles of the nocturnal in-
duction of pineal MKP-1 and AA-NAT expression reveal that
pineal MKP-1 mRNA and protein levels increase at night
more rapidly than AA-NAT mRNA and protein and the in-
duction of pineal MKP-1 expression is less sustained. This
suggests possible diﬀerences in transcriptional and protein-
level control between MKP-1 and AA-NAT. Because this
diﬀerence in temporal proﬁles is replicated in pinealocyte cell
culture, it will be possible to characterize in detail the molec-
ular diﬀerences in the control mechanisms involved in MKP-1
and AA-NAT induction and degradation.
Our studies also raise the question of what MAPKs are
substrates for MKP-1 in the pineal gland. Studies in other cell
types have indicated that p38MAPK is the preferred substrate
for MKP-1 [33] and p42/44MAPK activity is normal after de-
letion of MKP-1 gene in mice [34]. In the case of the rat pineal
gland, we have previously shown that NE treatment increases
phosphorylated p42/44MAPK that peaks at 5 min and is back to
basal levels at 1 h without having an eﬀect on p42/44MAPK
protein [11]. This precedes the NE induction of MKP-1 ex-
pression that peaks at 1 h and declines gradually over the next4 h. In comparison, NE increases phosphorylated p38MAPK at
1 h and the increase is sustained for 4 h [15]. Together, these
results suggest that MKP-1 may mediate the rapid decline in
p42/44MAPK and the delayed activation of p38MAPK.
The observations in this report of MKP-1 add to the
growing body of the literature on a role of the MAPK pathway
in circadian biology. The coupling of light to resetting of the
SCN clock in rats [35], regulation of AA-NAT oscillation in
the chick pineal gland [36], and regulation of AA-NAT by
MAPKs in the pineal gland [13,15] point to the existence of a
common conserved regulatory MAPK mechanism associated
with the biological clock.
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